Peter W. Sonsini

Insider Reports History

Entity
Individual
Location
2855 Sand Hill Road, Menlo Park, CA
Signature
/s/ Louis Citron, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter W. Sonsini:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7.69M $146M $19.00 Jun 28, 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3M $5.7M $1.90 Apr 11, 2022 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 949K $1.92M $2.02 Apr 11, 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 270 $3.32K $12.28 May 2, 2022 Indirect
Eargo, Inc. 10%+ Owner Common Stock 821 $2.13K $2.59 May 24, 2021 Indirect
IonQ, Inc. 10%+ Owner Common Stock 70 $925 $13.21 Nov 16, 2022 Indirect
Arcellx, Inc. 10%+ Owner Common Stock 12 $663 $55.27 Dec 20, 2022 Indirect
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 24 $360 $15.00 Oct 19, 2022 Indirect
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 54 $39.60 $0.73 Jun 8, 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 1.85M Oct 18, 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 7-Year Common Stock Warrant 1.85M Oct 18, 2021 Indirect
Bright Health Group Inc. 10%+ Owner Series A Convertible Perpetual Preferred Stock 125K Jan 3, 2022 Indirect
Bright Health Group Inc. 10%+ Owner Series B Convertible Perpetual Preferred Stock 100K Oct 17, 2022 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 $2.96 Jun 28, 2021 Indirect
Robinhood Markets, Inc. Director Common Stock 0 $34.32 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Series B Redeemable Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Series C Redeemable Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Series D Redeemable Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Series E Redeemable Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Series F Redeemable Convertible Preferred Stock 0 Aug 2, 2021 Indirect
Robinhood Markets, Inc. Director Tranche I Convertible Promissory Note 0 Aug 2, 2021 Indirect

Insider Reports Filed by Peter W. Sonsini

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACLX Arcellx, Inc. Dec 20, 2022 7 $0 4 Dec 22, 2022 10%+ Owner
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
IONQ IonQ, Inc. Nov 16, 2022 7 $0 4 Nov 18, 2022 10%+ Owner
AVEO AVEO PHARMACEUTICALS, INC. Oct 19, 2022 9 $0 4 Oct 21, 2022 10%+ Owner
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 10%+ Owner
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 10%+ Owner
HOOD Robinhood Markets, Inc. May 2, 2022 10 $0 4 May 4, 2022 Director
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 3 $12.5M 4 Apr 13, 2022 10%+ Owner
HOOD Robinhood Markets, Inc. Jan 28, 2022 10 $0 4 Feb 1, 2022 Director
BHG Bright Health Group Inc. Jan 3, 2022 2 $200M 4 Jan 5, 2022 10%+ Owner
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
HOOD Robinhood Markets, Inc. Nov 10, 2021 4 $0 4 Nov 12, 2021 Director
HOOD Robinhood Markets, Inc. Oct 27, 2021 4 $0 4 Oct 29, 2021 Director, 10%+ Owner
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner
HOOD Robinhood Markets, Inc. Aug 2, 2021 20 $77.1M 4 Aug 3, 2021 Director, 10%+ Owner
HOOD Robinhood Markets, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
BHG Bright Health Group Inc. Jun 28, 2021 22 $35M 4 Jun 30, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 10%+ Owner
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
DM Desktop Metal, Inc. Jun 8, 2021 7 $0 4 Jun 10, 2021 10%+ Owner
EAR Eargo, Inc. May 24, 2021 4 $0 4 May 26, 2021 10%+ Owner